Hangzhou Chongpangpang Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Hangzhou Chongpangpang Technology Co., Ltd. has 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in Hangzhou City.
Rm B1-3-156, No. 198 Qidi Rd.
Hangzhou City 311200 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hangzhou Chongpangpang Technology Co., Ltd.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Hangzhou Chongpangpang Technology Co., Ltd. have?
Hangzhou Chongpangpang Technology Co., Ltd. has 15 U.S. trademarks filed with the USPTO.
What trademark classes does Hangzhou Chongpangpang Technology Co., Ltd. file in?
Hangzhou Chongpangpang Technology Co., Ltd. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What is Hangzhou Chongpangpang Technology Co., Ltd.'s trademark registration success rate?
Hangzhou Chongpangpang Technology Co., Ltd. has a 0% trademark registration rate, with 0 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.